用于自发冠状动脉剖析的药物:一些不可信任的选择
Ivan Ilic1,2, Anja Radunovic1, Stefan Timcic1
1Department of Cardiology, Institute for Cardiovascular Diseases Dedinje, Belgrade, Serbia.
Frontiers in cardiovascular medicine
|November 29, 2023
概括
自发冠状动脉剖析 (SCAD) 治疗需要避免服用某些药物,如纤维解质剂和抗凝剂. 建议使用阿司匹林和克洛皮多格勒的双重抗血小板治疗 (DAPT),以及β-阻断剂,以防止SCAD复发.
科学领域:
- 心脏病学 心脏病学
- 血管医学 血管医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 自发冠状动脉解剖 (SCAD) 是急性冠状动脉综合征的一个不常见的原因,经常被误诊和治疗不当.
- 有限的随机试验在建立基于证据的SCAD管理医疗指南方面存在挑战.
- 临床表现对于指导SCAD患者的医疗和干预方法至关重要.
研究的目的:
- 概述自发冠状动脉剖析的最佳医疗和干预管理策略.
- 为适当的药理疗法提供指导,包括抗血小板和心血管药物.
- 根据目前的理解,突出应避免的药物和建议SCAD患者服用的药物.
主要方法:
- 审查和综合现有临床知识和SCAD治疗建议.
- 强调区分高风险和低风险血管学特征以指导治疗.
- 讨论药物类别,包括抗血小板剂,抗凝固剂,β-阻断剂和心力衰竭疗法.
主要成果:
- 在SCAD中应避免使用纤维溶解剂和抗凝剂,因为存在血液瘤扩张的风险.
- 建议使用阿司匹林和克洛皮多格勒的双重抗血小板治疗 (DAPT);应避免使用强大的P2Y12抑制剂.
- 建议使用β-阻断剂来预防SCAD复发;针对心力衰竭的特殊药物可用于减少喷射分数.
结论:
- 目前的SCAD管理强调避免促出血剂和使用DAPT,并特别考虑高风险特征.
- 建议使用β阻塞剂和针对心力衰竭的指导方针导向的药物治疗.
- 需要从国家注册和随机试验中获得进一步的数据来完善SCAD治疗方案.
相关概念视频
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
533
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
533
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
532
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
532
01:16Antianginal Drugs: Nitrates and β-Blockers
598
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
598
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
1.0K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.0K
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
747
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
747
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
845
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
845